Two Cases of Subsequent Hepatocellular Carcinoma in Immune Checkpoint Inhibitor–Responsive NSCLC: A Case Report

Two Cases of Subsequent Hepatocellular Carcinoma in Immune Checkpoint Inhibitor–Responsive NSCLC: A Case Report

As novel therapeutic regimens continue to lead to increased survival of patients with lung cancer, it is imperative to remain mindful of the accompanying increase in the incidence of new primary malignancies. Although the most common secondary malignancies in patients with lung cancer have historica...

Full description

Bibliographic Details
Main Authors: Tia Cheunkarndee, BA, Matthew Z. Guo, BA, Jacqueline E. Birkness-Gartman, MD, Kiyoko Oshima, MD, Cheng Ting Lin, MD, Kristen A. Marrone, MD
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:JTO Clinical and Research Reports
Subjects:
Non–small cell lung cancer
Immune checkpoint inhibitor therapy
Hepatocellular carcinoma
Multiple primary malignancies: Case report
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364322001722

Internet

http://www.sciencedirect.com/science/article/pii/S2666364322001722

Similar Items